Percutaneous radiofrequency ablation for treatment of hepatoblastoma recurrence

Abstract

Radiofrequency ablation (RFA) has been widely reported as a minimally invasive treatment for liver tumours in adults, but has not been documented as a treatment for hepatoblastoma in a child. We report a 2-year-old boy with local recurrence of hepatoblastoma after partial hepatectomy. Percutaneous RFA was performed under real-time sonographic guidance. There was no imaging evidence of recurrence after a follow-up of 2 years. We consider this a promising technique in children.

Rare hepatic malignant tumors: dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature

“…Liver transplantation for HB also has been recommended [92]. New methodologies have been applied for local control, including TACE [93] and radiofrequency ablation (RFA) [94] for advanced-stage and metastatic tumors.…”

Radiofrequency ablation in the treatment of liver tumors in children

“…To our knowledge, our case report is the first showing that RFA can be a successful treatment of liver metastasis from Wilms' tumor and of primary HB. We also encountered a case in which RFA was used to treat a recurrent HB with a good result [21]. Reports on use of percutaneous RFA in recurrent Wilms' tumor and on a primary renal Wilms' tumor has shown promising results [22,23].…”

Interventional oncology: the future

“…RFA has been used to treat Wilms tumor in the kidney [36]. There has been extensive experience of RFA in the adult liver but limited publications in pediatrics [37]. RFA is specifically indicated to ablate unresectable liver lesions and painful bone tumors [38].…”